Drug intelligence / Profile preview

(S)-1-phenyl-1-[4-(9H-purin-6-yl)phenyl]methanamine

Development stage: Unknown
Modality: Small Molecules

Overview

(S)-1-phenyl-1-[4-(9H-purin-6-yl)phenyl]methanamine is a synthetic small molecule belonging to the diphenylmethane class of organic compounds, characterized by a central methanamine group substituted with both phenyl and purin-substituted phenyl rings. It has an experimental status and is not approved for clinical use. The compound's mechanism of action, pharmacological activity, and therapeutic indications are currently unknown or uncharacterized in the literature. No information on its biological targets or clinical development has been reported[1][2][3][8].

Other names: (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE(S)-phenyl[4-(9H-purin-6-yl)phenyl]methanamine

Beyond the preview

Go deeper on (S)-1-phenyl-1-[4-(9H-purin-6-yl)phenyl]methanamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-1-phenyl-1-[4-(9H-purin-6-yl)phenyl]methanamine.

Explore the full profile